The goal of the present study was to determine whether loss of the insulin receptor alters the molecular landscape of the intestinal mucosa, using intestinal-epithelial insulin receptor knockout (IE-irKO) mice and both genetic (IR fl/fl and Villin-cre) controls. Quantitative proteomic analysis by liquid chromatography mass spectrometry was applied to jejunal and colonic mucosa from mice fed a normal chow diet and mice fed a Western diet (WD). Jejunal mucosa from IE-irKO mice demonstrated alterations in all intestinal cell lineages: Paneth, goblet, absorptive, and enteroendocrine cells. Only goblet and absorptive cells were affected in the colon. Also, a marked effect of WD consumption was found on the gut proteome. A substantial reduction was detected in Paneth cell proteins with antimicrobial activity, including lysozyme C-1, angiogenin-4, cryptdin-related sequence 1C-3 and -2, a-defensin 17, and intelectin-1a. The key protein expressed by goblet cells, mucin-2, was also reduced in the IE-irKO mice. Proteins involved in lipid metabolism, including aldose reductase-related protein 1, 15-hydroxyprostaglandin dehydrogenase, apolipoprotein A-II, and pyruvate dehydrogenase kinase isozyme 4, were increased in the mucosa of WD-fed IE-irKO mice compared with controls. In contrast, expression of the nutrient-responsive gut hormones, glucose-dependent insulinotropic polypeptide and neurotensin, was reduced in the jejunal mucosa of IE-irKO mice, and the expression of proteins of the Ptype adenosine triphosphatases and the solute carrier-transporter family was reduced in the colon of WD-fed IE-irKO mice. In conclusion, IE-irKO mice display a distinct molecular phenotype, suggesting a biological role of insulin and its receptor in determining differentiated cell specificity in the intestinal epithelium. (Endocrinology 158: 2470(Endocrinology 158: -2485(Endocrinology 158: , 2017 
I
nsulin is a key hormone in blood glucose regulation, facilitating cellular uptake of glucose in several tissues and, therefore, serving as an important therapeutic approach in the treatment of diabetes. However, the insulin receptor (IR) is ubiquitously expressed, including in many tissues that are not confined to the maintenance of glucose homeostasis. Hence, expression of the IR in the small and large intestine has been known for decades (1) (2) (3) (4) (5) (6) . However, despite high levels of the IR in both the villus and the crypt cells of the intestinal epithelium (IE), the biological role of insulin therein is not fully understood.
The gastrointestinal tract is a highly dynamic environment with multiple distinct regions, cell types, and biological purposes. The upper part, comprising the mouth, esophagus, and stomach, processes food to digestible components, which are then further digested and absorbed in the small intestine. Paneth cells at the base of the crypt are important in maintenance of the barrier integrity of the small intestine, through secretion of antimicrobial compounds (7) . Moreover, Paneth cells feed the neighboring stem cells to enable self-renewal and differentiation of the IE (8) . In contrast, the colon, which contains the highest concentration of luminal bacteria, is enriched in immune and mucus-producing goblet cells (9) . Finally, enteroendocrine cells are distributed throughout the IE, with highest numbers of cholecystokinin-, glucosedependent insulinotropic polypeptide (GIP)-, and secretinexpressing cells in the proximal intestine, compared with the more distally localized glucagonlike peptide-1-, glucagonlike peptide-2-, neurotensin (NTS)-, and peptide YY-expressing cells (10) . Thus, the cells of the intestinal tract are extremely diverse, with crucial functions in host protection, metabolism, and hormonal secretion.
Different models and approaches have recently been applied to study the role of insulin and the IR in the intestinal environment, including both gain and loss of function studies (11) (12) (13) (14) . Most studies to date have focused on the known or suspected functional effects of insulin in the gut based on findings in other tissues, rather than taking an unbiased approach. Furthermore, although one group has reported a microarray analysis of jejunal epithelial cells from mice lacking the IE-IR compared with floxed control mice (14) , these data were not translated to include the more functionally relevant proteome. The aim of the present study was, therefore, to characterize the molecular phenotype of the small and large intestinal mucosa from IE-IR knockout (IE-irKO) mice, by conducting an unbiased liquid chromatography-mass spectrometry (LC-MS)-based global quantitative proteome analysis. Because only a single study to date (11) has examined both of the genetic controls used to generate the IE-irKO mice (12) (13) (14) , we analyzed both IR fl/fl and Villin-cre recombinase (Vil-Cre) mice as controls for the KO mice. We also examined two groups of mice, one fed a chow diet and one fed a high-fat, high-sucrose Western diet (WD), given previous reports of small alterations in nutrient handling in IE-irKO mice consuming a 60% high-fat diet (12, 14) . Collectively, these findings should provide a valuable resource for the development of testable hypotheses on the role of insulin in the intestinal tract.
Methods

Mice and diets
Transgenic IE-ir KO C57Bl/6J mice with constitutive knockout of IR in the intestinal epithelium were bred and genotyped (Vil-Cre:IR fl/fl ) by The Jackson Laboratory (Bar Harbor, ME; for more details please see www.jax.org). Two control mouse strains were included: mutated/loxP-floxed control littermates [IR fl/fl ; B6.129S4(FVB)-Insrtm1Khn/J], and the parental transgenic control mice, which were colony mates [Vil-Cre; B6.SJL-Tg(Vil-cre)997Gum/J]. The mice were housed at the University of Toronto (Toronto, ON, Canada) and were approved by the Novo Nordisk ethical review council and the University of Toronto animal care committee. At arrival, the mice were 6 weeks old and were allowed 1 week of acclimatization before transfer to ad libitum rodent chow (Teklad rodent diet 2018; Envigo Inc., Huntingdon, UK) or a WD (D12079B, with 41% calories from fat and 29% from sucrose; Research Diets, Inc., New Brunswick, NY) for 12 weeks. Our related functional studies on these mice (11) demonstrated a profound sex-genotype interaction for the female Vil-cre mice. Therefore, to prevent the introduction of a type II error due to this confounder, only male mice were examined in the present study [n = 4; Fig. 1(a) ]. This also permitted determination regarding our inability to detect a marked phenotype in the Vil-cre males (11) resulted from functional adaptation to crerecombinase expression in the intestinal epithelium.
Intestinal dissection and tissue collection
The mid-jejunum (defined as 50% of the linear length of the jejunum plus ileum) and proximal colon (top 2 cm) were dissected at euthanasia [ Fig. 1(a) ]. Each tissue was flushed with ice-cold phosphate-buffered saline, divided into 1-to 2-cm segments, frozen on dry ice, and stored at 280°C. Additional 2-cm sections from the mid-jejunum were fixed overnight in 10% formalin before paraffin embedding and sectioning for immunofluorescence.
Sample preparation for MS analysis
Frozen tissue was semithawed on ice before collection of the mucosa by scraping into lysis buffer (6 M guanidinium hydrochloride, 50 mM HEPES; pH 8.5), followed by homogenization with 5-mm stainless steel beads (Qiagen Inc., Hilden, Germany) in TissueLyser II (Qiagen Inc.) and boiling in a BioRuptor (Diagenode, Liege, Belgium). Protein was quantified using the BCA Protein Assay kit (Thermo Fisher Scientific Life Sciences, Waltham, MA), and 100 mg of protein was used as input for the LC-MS analyses. The protein lysate was reduced [10 mM Tris-(2-carboxyethyl)phosphine] and alkylated (40 mM 2-chloroacetamide) for 30 minutes and subsequently digested to peptides in a two-step reaction using lysyl endopeptidase C and trypsin. Enzyme activity was quenched by adding 2% trifluoroacetic acid to a final concentration of 1%. The peptide samples were desalted using Sep-Pak columns (Waters, Milford, MA), as previously described (15) . The eluted peptides were frozen on dry ice and concentrated to dryness by vacuum centrifuge (model no. SC250EXP; Thermo Fisher Scientific Life Sciences). For tandem mass tag labeling, each sample was reconstituted in 50 mM HEPES, and 20 mg peptide was taken forward for individual sample labeling according to the manufacturer's instructions in a six-plex manner [ Fig. 1(b) ]. After peptide labeling, the samples were combined, and 30 mg total peptide for each pooled sample was subjected to strongcation-exchange fractionation to maximize proteome coverage (16) . The six eluted fractions for each sample were frozen on dry ice, concentrated by vacuum centrifuge, and reconstituted in 1% trifluoroacetic acid and 2% acetonitrile for LC-MS analysis.
LC-MS analysis
For each strong cation exchange fraction, the peptides were loaded onto a 2-cm C18 trap column (model no. 164705; Thermo Fisher Scientific Life Sciences), connected in-line to a 50-cm C18 reverse-phase analytical column (Thermo EasySpray ES803; Thermo Fisher Scientific Life Sciences) using 100% Buffer A (0.1% formic acid in water) at 750 bar, using the Thermo EasyLC 1200 uHPLC system (Thermo Fisher Scientific Life Sciences), with the column oven at 45°C. The peptides were eluted over a 200-minute gradient ranging from 5% to 30% of 80% acetonitrile, 0.1% formic acid at 250 nL/min, and the QExactive HF (Thermo Fisher Scientific Life Sciences) was run using a ddMS2 top 20 method. Full MS spectra were collected at a resolution of 60,000, with an automatic gain control target of 3 3 10 6 or maximum injection time of 20 ms and a scan range of 350 to 1800 m/z. Ions were isolated in a 1.4-m/z window, with an automatic gain control target of 1 3 10 5 or a maximum injection time of 50 ms, fragmented with a normalized collision energy of 30. The resulting MS2 spectra were obtained at 15,000 resolution. Dynamic exclusion was set to 45 seconds, and ions with a charge state less than +2, greater than +6, or unknown were excluded. LC-MS performance was verified for consistency by running complex cell lysate quality control standards, and chromatography was monitored to check for reproducibility. Each sample was run in biological triplicate, and technical duplicates were generated for one colon and one jejunum sample. The reproducibility of our analyses is depicted in Fig. 1(c) . The MS data were deposited at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange. org) via the PRIDE partner repository with the data set identifier PXD005932 (17) .
Immunofluorescence
The KO of the IR in the intestinal epithelium was validated by immunofluorescence in the duodenum, jejunum, and colon, as reported previously (11) . In brief, four pieces spread over the length of the intestinal segments from each mouse were collected and processed to paraffin for transverse sectioning. Each paraffin block thus provided four distinct intestinal segment levels per section for quantitative analyses of the cell types. Lysozyme C1 (LYZ1), mucin-2 (MUC2), and GIP were visualized in jejunal sections by immunofluorescence using rabbit anti-lysozyme [1:500; catalog no. A0099; Dako, Carpinteria, CA; research resource identifier (RRID), AB_2341230], rabbit anti-MUC2 (1:200; catalog no. sc-15334; Santa Cruz Biotechnology, Santa Cruz, CA; RRID, AB_2080411) and rabbit anti-GIP (1:500; catalog no. NBP1-86422; Novus Biologicals, Littleton, CO; RRID, AB_11004483), and the total epithelial area was measured using mouse anti-Ecadherin (5 mg/mL; model no. 610182; BD Biosciences, Franklin Lakes, NY; RRID, AB_397581). Donkey anti-rabbit (Cy3; RRID, AB_2307443) and donkey anti-mouse (Cy2; RRID, AB_2340827) from Jackson ImmunoResearch Laboratories Inc. (West Grove, PA) were used for detection, and the slides were scanned on an Olympus VS120 slide scanner using a 320 (numerical aperture, 0.75; 0.33 mm/pixel) objective. Visiopharm software (Visiopharm A/S, Hørsholm, Denmark) was used to measure the total immunopositive areas, and the Paneth, goblet, and GIPexpressing cell areas were calculated relative to the total epithelial area.
Statistics, analyses, and software
The generated mass spectrometry raw files were analyzed using MaxQuant, version 1.5.2.8 (18) , with TMT MS2 quantitation enabled in the six-plex format. Variable modifications were set as oxidation (M), acetyl (protein N-term), Gln→pyro-Glu, and Glu→pyro-Glu. Fixed modifications were set as carbamidomethyl (C), and the false discovery rate was set to 1%. The resulting protein group file was subsequently analyzed for statistical significance using the Limma package (19) in the R Statistical Framework, version 3.1.3 [R Foundation, Vienna, Austria; https://www.r-project.org/; Fig. 1(b) ]. Data were further processed in Perseus, version 1.5.1.6 (Max Planck Institute of Biochemistry, Munich, Germany) (20) to sort the proteins significantly differentially expressed in the KO mice compared with the two control mice. For proteins to be included, the following criteria were applied: P # 0.05 in either KO versus IE-irKO fl/fl or in KO versus Vil-Cre and P $ 0.05 in IE-irKO fl/fl versus Vil-Cre. Statistical analysis of the immunofluorescence data was performed using the R statistical software package including diet and genotype and their interaction as covariates in the analysis followed by a Tukey post hoc test. These data are expressed as the adjusted mean (lsmeans) 6 the 95% confidence interval (21) . Statistical significance was defined by P # 0.05.
Principle component analysis was performed in R statistical software (22) , and hierarchical clustering was analyzed in Perseus, version 1.5.0.9 (Max Planck Institute of Biochemistry). Venn diagrams were generated using VennDIS (23), Panther (24) , and Ingenuity Pathway Analysis (IPA; Ingenuity Systems, Qiagen Bioinformatics, Redwood, CA) were used to classify the proteins and biological processes.
Results
Global proteome analysis of jejunal and colonic mucosa from IE-irKO and control mice
In-depth quantitative proteome analyses were conducted using LC-MS on jejunal and colonic mucosa from male IE-irKO mice and the genetic control mice, IR fl/fl and Vil-Cre, fed a normal or WD for 12 weeks [ Fig. 1(a) ]. As previously reported (11), the WD-fed mice demonstrated a weight gain of 80% to 100%, with no substantial difference in bodyweight gain among the three genotypes. A total of 7931 proteins were identified in the mucosal samples, with 6648 proteins in the jejunum and 6650 proteins in the colon. To be included in the data analysis, the proteins were required to be quantified in at least three independent biological replicates (n $3). The number of identified proteins in the jejunum and colon was thus reduced to 6081 and 6186, respectively 
Both diet and genotype contribute to variability of the data set
Principal component analysis showed that the proteome of mice fed a chow diet was distinct from that of mice fed a WD (55% and 47% variability in jejunum and colon, respectively). The three genotypes of mice were thus analyzed separately by diet [19% and 24% variability in jejunum and colon, respectively; Fig. 2(a) ]. In the jejunum, proteins from chow-fed Vil-Cre mice and, to a lesser extent, IE-irKO WD-fed mice accounted for the genotype effect. In contrast, in the colon, the genotype effect was primarily evident in the IE-irKO WD-fed mice. This segregation of the data by diet and genotype was supported by unsupervised hierarchical clustering analysis [ Fig. 2(b) ]. Furthermore, the jejunal and colonic mucosa of the WD-fed IE-irKO mice displayed the largest numbers of relevant proteins (36 and 70 proteins, respectively), reflected in both the principal component analysis and the hierarchical clustering analysis. These numbers were reduced to 22 and 7 in the jejunum and colon, respectively, of chow-fed IEirKO. Thus, relevant changes in the molecular phenotype of the intestinal mucosa of the IE-irKO mice were most profound when the mice were challenged with the WD.
When mice were compared by genotype within each diet group, the jejunal mucosa from IE-irKO mice was found to be more distinctly different from the Vil-Cre mice (13 relevant proteins) than that from the IR fl/fl mice [5 relevant proteins; Fig. 2(c) ]. The proteome of the VilCre mice was also different from the IR fl/fl mice (four proteins), consistent with our in vivo phenotype data showing that the female Vil-Cre mice differ in a number of parameters compared with the IE-irKO and IR fl/fl mice (11) . When challenged with a WD, a large overlap was found in the total number of relevant proteins in the jejunal mucosa from IE-irKO mice compared with the two control groups (18 proteins in total: 12 vs IR fl/fl and 6 vs Vil-Cre mice). Similar differences were seen when comparing the proteomes obtained from the colonic mucosa. However, only one protein was found to be substantially reduced in both the jejunal (chow-fed and WD-fed) and colonic mucosa (chow-fed) of IE-irKO mice, which was the goblet cell marker, MUC2 [ Fig. 2(d) ].
Functional enrichment analysis identified enzymes and transporters to be altered in the jejunal and colonic mucosa of IE-irKO mice Most of the relevant proteins found to be differently expressed in the jejunal and colonic mucosa were categorized as enzymes (Fig. 3 ). Of these, peptidases, phosphatases, and kinases were the most abundant in the jejunum. Ion channels, transcription regulators, and transporters were also classified among the relevant proteins. Similar results were found in the colonic mucosa, although, in this tissue, cytokines also contributed slightly to the list of relevant proteins. Several biological processes were also identified based on these proteins, of which the Panther category "metabolic process" was the most abundant in both jejunal (28% and 43% for chow and WD, respectively) and colonic (29% and 31% for chow and WD, respectively) mucosa (data not shown).
All four intestinal cell lineages were affected in the jejunal mucosa of IE-irKO mice
Proteins specific for Paneth, goblet, and enteroendocrine cells and enterocytes were found to be differentially expressed in the IE-irKO compared with the control mouse jejunal mucosa (Figs. 4 and 5 ).
Paneth and goblet cells
In chow-fed IE-irKO mice, almost 30% of the relevant proteins were Paneth cell secretory products, including LYZ1, angiogenin-4, the cryptdin-related proteins CRS1C-2 and -3, a-defensin 17, and intelectin-1a (ITLN1), all of which were substantially reduced compared with both groups of control mice (Fig. 4) . WDchallenged IE-irKO mice also exhibited altered expression of Paneth cell proteins; however, the effect was not as profound as in the mice fed a chow diet, because only CRS1C-3 and a-defensin 17 were significantly decreased and a-defensin 4 was significantly increased in the IE-irKO mice (Fig. 5) . Immunostaining confirmed the loss of LYZ1 expression (as normalized to E-cadherin; control) relative to the lack of change in the chow-fed IE-irKO mucosa compared with both groups of control mice [ Fig. 6(a) ]. Finally, ingestion of a WD was found to decrease LYZ1 expression in the two control groups only. MUC2, which is the key marker of goblet cells, was significantly downregulated in the jejunum of both chowand WD-fed IE-irKO mice compared with the control mice (Figs. 4 and 5) . Immunostaining for MUC2 did not demonstrate any remarkable changes in goblet cell numbers in the jejunum of the KO mice [ Fig. 6(b) ]. However, several proteins involved in mucin production and secretion, including zymogen granule membrane protein 16, calcium-activated chloride channel regulator 1, the IgGFc-binding protein Fcgbp, and anterior gradient protein 2 homolog, were also reduced in these tissues.
Enteroendocrine cells
GIP and NTS secreted from the enteroendocrine K and N cells, respectively, were substantially decreased in the jejunal mucosa from IE-irKO mice. The GIP levels were decreased in both chow-and WD-fed IE-irKO mice (Figs. 4 and 5) , although immunostaining did not demonstrate any change in total K cell numbers [ Fig. 6(c) ]. In contrast, NTS expression was substantially reduced only in WD-fed mice (Fig. 5) .
Enterocytes
Several proteins involved in lipid absorption, transport, and degradation were substantially altered in the jejunum of IE-irKO mice challenged with a WD (Fig. 5) . Apolipoprotein A (APOA)-II, which facilitates high-density lipoprotein (HDL) reverse cholesterol transport, was elevated, consistent with a reduction in SEC14-like protein 2, a downstream enzyme of the cholesterol biosynthesis pathway. Moreover, the apically expressed long-chain fatty acid transporter, long-chain fatty acid transport protein 4 (SLC27A4), was decreased in the WD-IE-irKO mucosa. An increase in aldose reductase-related protein 1, an enzyme involved in the detoxification of lipid peroxides, including bile acids (25) , was also detected. Furthermore, pyruvate dehydrogenase kinase isozyme 4 (PDK4), which favors fatty acid over glucose oxidation was increased in the mucosa of IE-irKO mice fed a WD. Based on these findings, IPA indicated a substantial reduction of global lipid levels in WD-fed IE-irKO jejunum [Z = 22.015; Fig. 7(a) ]. A similar trend, albeit less pronounced, was found in the chow-fed IE-irKO jejunum [ Fig. 7(b) ].
A number of proteins that play a role in glucose metabolism were also altered in the IE-irKO WD-fed mice, most notably, phosphoenolpyruvate carboxykinase (PCK1), the key regulator of gluconeogenesis, which was upregulated, and pyruvate kinase (PKLR), which catalyzes the rate-limiting step of glycolysis, which was downregulated (Fig. 5) . Finally, the transcriptional inhibitor, zinc finger and BTB domain containing 20, was suggested by IPA to play a role in these changes in WDfed IE-irKO mice owing to increases in the downstream molecules, PDK4, PCK1, and aldose reductase-related protein 1 [ Fig. 7(c) ]. Although not substantial, a similar pattern was found in chow-fed IE-irKO mice [ Fig. 7(d) ].
Other relevant proteins
The enterocyte cell differentiation marker, intestinal alkaline phosphatase, was reduced in the jejunal mucosa of WD-fed IE-irKO mice (Fig. 5) . Several proteins related to retinoid metabolism (carboxylic ester hydrolase, retinal dehydrogenase 1, and retinol-binding protein 2), which plays an important role in cell differentiation, proliferation, and immune function, were also significantly reduced in WD-fed IE-irKO mice compared with control mice (Fig. 5) . 
Two intestinal cell lineages were affected in the colonic mucosa of IE-irKO mice
Although Paneth cells are not found in the colon, relevant changes in the proteome of both goblet cell and colonocyte markers were found in IE-irKO mice. However, no changes in enteroendocrine cell hormones were detected (Fig. 8) .
Goblet cells
As also found in the jejunum, expression of the goblet cell marker, MUC2, was decreased in the colon of chowfed IE-irKO mice [ Fig. 8(a) ]. No change in MUC2 levels was detected in WD-fed KO mice.
Colonocytes
A general downregulation of the solute carrier (SLC) family of membrane transport proteins was found in IE-irKO mice compared with the control mice [ Fig. 8(b) ]. The SLC proteins are known to transport various substrates, including, not only nutrients, but also drugs and xenobiotics. In particular, the SLC25 family was affected in IE-irKO mice, including SLC25A3 (phosphate transporter), SLCA4,
SLCA5 [adenosine 5
0 -diphosphate/adenosine triphosphate (ATP) carriers], and SLCA20 (carnitine/acylcarnitine carrier), which are embedded in the inner mitochondrial membrane (26, 27) . Several additional mitochondrial-associated proteins were substantially reduced in the colon of WD-fed IEirKO mice, including nicotinamide adenine dinucleotide hydrate dehydrogenases involved in the electron transport chain, B5 and B8, and cytochrome C oxidase subunit 2 [ Fig.  8(b) ]. Mitochondrial carrier homolog 2, which was also reduced, is associated with the outer mitochondrial membrane and is involved in both mitochondrial metabolism and programmed cell death (28, 29) .
The colonic epithelium also enables the ATPdependent directional transport of ions and water, through proteins of the P-type ATPase family: ATP1A1 and ATP1B1 (Na + /K + ATPase transporters), and ATP2A2 and ATP2B1 (Ca 2+ ATPase transporters), all of which were decreased in WD-fed IE-irKO mice compared with control WD-fed mice [ Fig. 8(b) ].
The major protein component associated with HDL is APOA-I, which was substantially increased in WD-fed IE-irKO mice [ Fig. 8(b) ]. Moreover, the iron-binding protein, hemopexin, which is transported to the liver via HDL (30), was increased. Consistent with this, the APOA-I-binding protein, transthyretin (31) , was also substantially increased in WD-fed IE-irKO mice [ Fig. 8(b) ]. Finally, other proteins that were substantially reduced in the colon of WD-fed IE-irKO mice included insulindegrading enzyme, and the protein Bax inhibitor 1, which has an important function in the regulation of cellular stress (32) . In contrast, carbonic anhydrase 6, which is believed to maintain mucosal pH, was significantly upregulated [ Fig. 8(b) ].
Discussion
The high expression of the IR in the intestinal tract suggests a role for insulin signaling in this tissue. Several recent studies have shown that, although the intestines of these mice develop fairly normally, the IE-irKO mice exhibit small changes in glucose and lipid profiles and associated alterations in jejunal messenger RNA (mRNA) transcript levels, in particular, in response to a high-fat, high-sucrose (or Western) diet (11) (12) (13) (14) . However, most of these studies failed to consider both of the foundational mouse lines used to generate the IE-irKO mice as controls. Also, only targeted molecules were examined at the protein level. The goal of the global proteome analysis on intestinal mucosa from mice deficient in the IR in the intestinal epithelium (and appropriate controls) was, therefore, to use an unbiased approach to identify the proteins and related pathways that play a role in the actions of insulin on the intestinal tract, under both physiologic conditions and in response to consumption of a high-fat, high-sucrose diet that mimics Western nutrient intake patterns. Molecular alterations in the mucosa of the IE-irKO mice were identified in all four major intestinal cell lineages. However, the most remarkable changes were detected in proteins related to mucosal host protection, IE cell differentiation, and nutrient homeostasis.
Mucosal host protection
In both chow-and WD-fed IE-irKO mice, a reduction was found in products secreted by Paneth cells, consistent with the demonstration of reduced Paneth cell numbers. Located in the small intestinal crypts, these cells play a key role in the release of antimicrobial substances to maintain symbiosis between the host cells and microbes. Most notably, compared with both IR fl/fl and Vil-Cre control mice, the IE-irKO mice demonstrated reductions in the expression of antimicrobial peptides (a-defensins, cryptdin-related sequences 2 and 3) and a ribonuclease (angiogenin-4) that target gram-positive and gramnegative bacteria (33) and in LYZ1, a b-1,4-glycosidase that acts on gram-positive bacteria. The Paneth and goblet cell innate immune effector, ITLN1, was also decreased in the jejunum of chow-fed IE-irKO mice (34) . These changes were more limited in KO mice fed a WD, although the decrease in LYZ expression was confirmed in both groups of KO mice by immunostaining. A previous study has similarly reported reductions in a-defensin (Defa1) and Lyz1 mRNA levels in chow-fed and high-fat-fed IE-irKO mice compared with IR fl/fl control mice. However, in contrast to the findings of the present study, the number of LYZ-positive cells was not altered by IE-irKO but was reduced by a 60% high-fat diet (12) .
The goblet cell-specific protein, MUC2, was also significantly reduced in the jejunum and colon of IE-irKO mice compared with both groups of control mice. Unexpectedly, these changes are not consistent with the finding that chronic administration of insulin reduces colonic MUC2 mRNA levels in male mice (11, 12) . As such, additional factors appear to regulate MUC2 protein levels, of which the most likely is release of the protein by the IE cell onto the apical surface. MUC2 is the key component of the mucous layer lining the intestinal epithelium and plays a crucial role in maintaining a symbiotic relationship between the bacteria and host cells in a healthy gut (9) . Proteins involved in mucous production and secretion by goblet cells were also substantially reduced in the jejunal mucosa. Thus, when taken with the findings on Paneth cell proteins, these data suggest alterations in host-protective processes in the absence of the IR, which could lead to impaired intestinal barrier integrity. However, neither permeability between epithelial cells nor the resistance of the jejunal and colonic tissue have been found to differ between the IE-irKO and control mice (11) . Furthermore, plasma lipopolysaccharide levels are not altered by IE-IR KO (11) . It remains possible that the jejunum of IE-irKO mice might demonstrate altered microbial composition and/or mucosal barrier function under conditions of intestinal stress. Nonetheless, to date, only the fecal microbiome of chow-fed KO mice has been examined, which was found to be the same as that of IR fl/fl mice (14) . Future studies will therefore require more specific analysis of the jejunal and colonic bacterial community, under both physiologic conditions and after intestinal challenge, such as in models of enteritis and colitis.
IE cell differentiation
In addition to mucosal defense factors, Paneth cells release intestinal stem cell niche regulators (i.e., Wingless/ Wnt, Notch ligands, and epidermal growth factor), which are important for crypt cell proliferation and differentiation (8, 35) . Although no changes were detected in the expression of these paracrine regulators at either the protein (present study) or mRNA (14) level, we have demonstrated that chronic high-dose insulin treatment reduces crypt depth in the proximal colon of IE-irKO mice compared with both genetic controls (11) . It is therefore interesting to speculate that insulin signaling might affect intestinal cell differentiation. Consistent with this possibility, the enterocyte cell differentiation marker, alkaline phosphatase, was reduced in IE-irKO mice, just as was the expression of the enteroendocrine hormones, GIP and NTS. Recently, evidence has been provided for an important role of the IR-downstream effectors, TSC2/ mTORC1, in regulating differentiation of the intestinal secretory cell lineage, including not only Paneth and goblet cells, but also enteroendocrine cells (36) . Furthermore, lower levels of key factors affecting retinoid metabolism were detected, which might affect the number of Lgr5-expressing stem cells in the crypt niche (37) . Alternatively, insulin is known to cross-talk with Wingless/Wnt signaling in the intestine by activating the downstream transcription factor, T-cell factor 4 (38), which is crucial for Paneth cell maturation and function (33, 39) . Together, these findings support the notion of a potential role for insulin/IR signaling in intestinal epithelial cell differentiation.
Nutrient homeostasis
Most of the relevant proteins detected after 12 weeks of a WD were involved in glucose and lipid regulation. Changes in the expression of the enzymes PCK1, PDK4, and PKLR indicated a shift in mucosal cell nutrient usage from oxidation of glucose toward gluconeogenesis and fatty acid oxidation in the WD-fed IR-deficient mice. IPA suggested that these changes are likely to be mediated through decreased activity of the transcription factor, zinc finger and BTB domain containing 20. These changes are also consistent with the known inhibitory effects of insulin on gluconeogenesis in the intestinal mucosa (40) , as well as the downregulation of PKLR, a glycolytic enzyme activated by insulin in the intestine (41) . During both starvation and insulin resistance such as in type 2 diabetes mellitus and obesity, Pdk expression is elevated in several metabolically active tissues (42) (43) (44) . Recent data have also shown increased expression of Pdk4 and Pdk2 in the jejunal mucosa from Zucker diabetic fatty rats (45) . Reductions in the Paneth and goblet cell marker, ITLN1, which enhances insulin-mediated glucose uptake in adipocytes (46) , further suggest that these changes in substrate usage might not be limited to enterocytes. Moreover, because obese and type 2 diabetic patients have reduced circulating ITLN1 levels (47, 48) , ITLN1 (also known as omentin) is believed to be important for enhancing insulin sensitivity, an effector function expected to be lost in the IR-deficient gut. Finally, although we, and others, did not detect any change in glucose tolerance in IE-irKO mice under chow diet, high-fat diet, or WD conditions (11, 12) , one study noted impaired glucose tolerance in male KO mice in response to aging and ingestion of a 60% high-fat diet (14) . These changes were associated with decreased glucose uptake by isolated IE cells, despite normal expression of sodium glucose transporter-1 (Slc5a1) and -2 (Slc5a2) (11, 14) , but are consistent with the effects of insulin to enhance small intestinal Slc5a1 mRNA levels and sodium glucose transporter-1 activity (11, 49) .
Expression of the long-chain fatty acid transporter 4, SLC27A4, was also substantially reduced in the jejunum of WD-fed IE-irKO mice, consistent with altered IE cell uptake of ingested fat. These data support our previous findings showing increased expression of Slc27a4 (by 1.8-fold) in mice treated with high-dose insulin (300 nmol/kg) (11) . Moreover, humans heterozygous for the Gly209Ser polymorphism in the Slc27a4 gene exhibit metabolic features of an insulin-resistant state (50) .Together, these findings suggest that lipid metabolism plays a dominant role over that of glucose in the IRdeficient gut, likely contributing to the reduced circulating levels of cholesterol reported under conditions of 60% high-fat feeding (12) .
In contrast to the small intestine, the colon is generally not considered a lipid metabolic tissue. However, APOA-I was increased in the colon of WD-fed IE-irKO mice, as was hemopexin, which not only associates with APOA-Icontaining HDL particles, but also prevents heme-induced oxidative stress (51) . APOA-I has previously been demonstrated to be expressed in the colon and, in particular, the proximal part, where it exerts a protective role in experimental colitis (52) . These data would suggest a role for the IR in regulating lipid-related proteins in the colon that, perhaps, might be more relevant under conditions of intestinal damage.
Two nutrient-responsive gut hormones secreted by enteroendocrine cells, GIP and NTS, were decreased in the jejunal mucosa of IE-irKO mice. Lower levels of GIP were found under both dietary conditions, but NTS was reduced only in WD-fed IE-irKO mice. Previous studies have noted either normal or fewer GIP-expressing cells and lower Gip mRNA levels in IE-irKO mice consuming a high-fat diet (12, 14) . Released in response to ingestion of glucose or fat, GIP, not only serves as an incretin hormone, but also stimulates fat deposition in adipocytes (53) . Also secreted on fat ingestion, NTS contributes to nutrient homeostasis through its actions to enhance intestinal fat absorption (54) . Mice deficient in either GIP signaling or NTS are thus resistant to diet-induced obesity (54, 55) . Consistent with these findings, we have shown that IE-irKO male (but not female) mice gain significantly less weight after 4 weeks of a WD compared with control animals (Vil-cre, IR fl/fl , and Vil-cre;IR fl/2 ), although this difference is lost after 12 weeks (11). Because male and female KO mice fed a 60% high-fat diet for #26 weeks do not demonstrate any weight differences compared with floxed controls, these findings suggest possible interactions between diet, weight gain, and the enteroendocrine hormones, GIP and NTS.
Of some interest, the jejunal proteome of chow-fed Vilcre mice diverged from that of both the KO and floxed mice. Consistent with this alteration, Vil-cre mice demonstrate marked changes in several parameters of intestinal growth and intestinal function (i.e., glucose handling) compared with both IE-irKO and IR fl/fl mice (11) . Although functional differences were noted, in particular, for the female Vil-cre mice, the results of the present study indicate that male Vil-cre mice also demonstrate phenotypic differences in their proteome compared with floxed and KO mice. Why these changes are not reflected at the functional level in the males remains unclear but is likely related to an improved ability to adapt to the expression of cre recombinase in the IE cells compared with the female mice. Furthermore, the Vil-cre mice used in the present study were not littermate controls but were obtained from the colony-mate parental line of mice used to generate the KO mice. Notwithstanding, expression of cre-recombinase alone has been previously reported to affect the function of intestinal enteroendocrine cells and pancreatic b cells (56, 57) . The present findings thus further emphasize the need for carefully controlled studies using both males and females for the genetic models used in research. Finally, the highest number of relevant proteins in IEirKO mice compared with the controls was detected in the colon (70 proteins). With the exception of MUC2, little overlap was noted in these proteins between the colon and jejunum. However, the most notable of the altered colonic proteins were the P-type ATPases and SLC transporters, which were downregulated in the WD-fed IE-irKO mice. Insulin has been shown to decrease both Appendix. Antibody Table   Peptide the expression and the activity of Na + /K + ATPase in enterocytes, despite its ability to promote glucose uptake by these cells (58, 59) . However, because glucose rarely reaches the colonic lumen under physiological conditions, other actions of this ATPase, such as maintenance of cellular volume, pH, and/or intracellular calcium, might be more relevant in the colonocyte (60) . Similar considerations are likely relevant to the observed decreases in the SLC family of proteins important for mitochondrial transport of phosphate, adenosine 5 0 -diphosphate/ATP and carnitine/acylcarnitine (26, 27) .
In conclusion, collectively, the results of the present study have demonstrated substantial alterations in the proteome of the IR-deficient murine intestinal mucosa, thereby supporting the hypothesis of an important biological role for insulin signaling in the small and large intestine. Among the most remarkable of these changes, cell differentiation, host protective functions, and nutrient handling were identified as pathways driven by expression of the IR in the intestinal epithelium. Together, these findings will serve as a resource for future studies on the role of insulin in the intestinal tract.
